#METABOLOMICS WORKBENCH ZJ309_20220719_052137 DATATRACK_ID:3356 STUDY_ID:ST002384 ANALYSIS_ID:AN003884 PROJECT_ID:PR001534
VERSION             	1
CREATED_ON             	October 16, 2022, 5:40 am
#PROJECT
PR:PROJECT_TITLE                 	Lipidomics Investigation of Curcumin and Epigallocatechin Gallate on
PR:PROJECT_TITLE                 	IgE-Mediated Degranulation of RBL-2H3 Cells
PR:PROJECT_SUMMARY               	In this study, an IgE-mediated RBL-2H3 cell degranulation model was firstly
PR:PROJECT_SUMMARY               	developed. Then, ultra-high-performance liquid chromatography coupled to mass
PR:PROJECT_SUMMARY               	spectrometry (UPLC-MS) was used to perform the non-targeted lipidomics study, in
PR:PROJECT_SUMMARY               	order to investigate the effects and mechanism of curcumin/EGCG on IgE-mediated
PR:PROJECT_SUMMARY               	RBL-2H3 cells degranulation.
PR:INSTITUTE                     	College of Marine Food and Biological Engineering, Jimei University
PR:LAST_NAME                     	Yang
PR:FIRST_NAME                    	Zhiqiang
PR:ADDRESS                       	No. 185 Yinjiang Road, Jimei District, Xiamen City, Fujian Province, China
PR:EMAIL                         	201911832016@jmu.edu.cn
PR:PHONE                         	0592-6181487
#STUDY
ST:STUDY_TITLE                   	Lipidomics study of curcumin and epigallocatechin gallate on IgE-mediated
ST:STUDY_TITLE                   	degranulation of RBL-2H3 cells
ST:STUDY_SUMMARY                 	This study provides novel insights into the potential anti-allergic mechanism of
ST:STUDY_SUMMARY                 	food-derived curcumin and EGCG, and then facilitates the discovery of drug
ST:STUDY_SUMMARY                 	target and the development of diagnostic methods for allergic diseases.
ST:INSTITUTE                     	College of Marine Food and Biological Engineering, Jimei University
ST:LAST_NAME                     	Yang
ST:FIRST_NAME                    	Zhiqiang
ST:ADDRESS                       	No. 185 Yinjiang Road, Jimei District, Xiamen City, Fujian Province, China
ST:EMAIL                         	201911832016@jmu.edu.cn
ST:PHONE                         	0592-6181487
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Rattus norvegicus
SU:TAXONOMY_ID                   	10116
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	PBS-1A	Treatment:Control	Model=Positive; RAW_FILE_NAME=PBS-1A.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-1B	Treatment:Control	Model=Positive; RAW_FILE_NAME=PBS-1B.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-1C	Treatment:Control	Model=Positive; RAW_FILE_NAME=PBS-1C.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-1D	Treatment:Control	Model=Positive; RAW_FILE_NAME=PBS-1D.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-1A	Treatment:Allergy group	Model=Positive; RAW_FILE_NAME=0-1A.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-1B	Treatment:Allergy group	Model=Positive; RAW_FILE_NAME=0-1B.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-1C	Treatment:Allergy group	Model=Positive; RAW_FILE_NAME=0-1C.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-1D	Treatment:Allergy group	Model=Positive; RAW_FILE_NAME=0-1D.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-1A	Treatment:After allergy, 10uM curcumin interventionfor 1h	Model=Positive; RAW_FILE_NAME=C10-1A.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-1B	Treatment:After allergy, 10uM curcumin interventionfor 1h	Model=Positive; RAW_FILE_NAME=C10-1B.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-1C	Treatment:After allergy, 10uM curcumin interventionfor 1h	Model=Positive; RAW_FILE_NAME=C10-1C.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-1D	Treatment:After allergy, 10uM curcumin interventionfor 1h	Model=Positive; RAW_FILE_NAME=C10-1D.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-1A	Treatment:After allergy, 30uM curcumin interventionfor 1h	Model=Positive; RAW_FILE_NAME=C30-1A.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-1B	Treatment:After allergy, 30uM curcumin interventionfor 1h	Model=Positive; RAW_FILE_NAME=C30-1B.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-1C	Treatment:After allergy, 30uM curcumin interventionfor 1h	Model=Positive; RAW_FILE_NAME=C30-1C.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-1D	Treatment:After allergy, 30uM curcumin interventionfor 1h	Model=Positive; RAW_FILE_NAME=C30-1D.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-1A	Treatment:After allergy, 200uM EGCG interventionfor 1h	Model=Positive; RAW_FILE_NAME=E200-1A.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-1B	Treatment:After allergy, 200uM EGCG interventionfor 1h	Model=Positive; RAW_FILE_NAME=E200-1B.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-1C	Treatment:After allergy, 200uM EGCG interventionfor 1h	Model=Positive; RAW_FILE_NAME=E200-1C.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-1D	Treatment:After allergy, 200uM EGCG interventionfor 1h	Model=Positive; RAW_FILE_NAME=E200-1D.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-1A	Treatment:After allergy, 500uM EGCG interventionfor 1h	Model=Positive; RAW_FILE_NAME=E500-1A.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-1B	Treatment:After allergy, 500uM EGCG interventionfor 1h	Model=Positive; RAW_FILE_NAME=E500-1B.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-1C	Treatment:After allergy, 500uM EGCG interventionfor 1h	Model=Positive; RAW_FILE_NAME=E500-1C.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-1D	Treatment:After allergy, 500uM EGCG interventionfor 1h	Model=Positive; RAW_FILE_NAME=E500-1D.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-3A	Treatment:Control	Model=Positive; RAW_FILE_NAME=PBS-3A.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-3B	Treatment:Control	Model=Positive; RAW_FILE_NAME=PBS-3B.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-3C	Treatment:Control	Model=Positive; RAW_FILE_NAME=PBS-3C.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-3D	Treatment:Control	Model=Positive; RAW_FILE_NAME=PBS-3D.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-3A	Treatment:Allergy group	Model=Positive; RAW_FILE_NAME=0-3A.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-3B	Treatment:Allergy group	Model=Positive; RAW_FILE_NAME=0-3B.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-3C	Treatment:Allergy group	Model=Positive; RAW_FILE_NAME=0-3C.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-3D	Treatment:Allergy group	Model=Positive; RAW_FILE_NAME=0-3D.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-3A	Treatment:After allergy, 10uM curcumin interventionfor 3h	Model=Positive; RAW_FILE_NAME=C10-3A.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-3B	Treatment:After allergy, 10uM curcumin interventionfor 3h	Model=Positive; RAW_FILE_NAME=C10-3B.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-3C	Treatment:After allergy, 10uM curcumin interventionfor 3h	Model=Positive; RAW_FILE_NAME=C10-3C.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-3D	Treatment:After allergy, 10uM curcumin interventionfor 3h	Model=Positive; RAW_FILE_NAME=C10-3D.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-3A	Treatment:After allergy, 30uM curcumin interventionfor 3h	Model=Positive; RAW_FILE_NAME=C30-3A.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-3B	Treatment:After allergy, 30uM curcumin interventionfor 3h	Model=Positive; RAW_FILE_NAME=C30-3B.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-3C	Treatment:After allergy, 30uM curcumin interventionfor 3h	Model=Positive; RAW_FILE_NAME=C30-3C.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-3D	Treatment:After allergy, 30uM curcumin interventionfor 3h	Model=Positive; RAW_FILE_NAME=C30-3D.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-3A	Treatment:After allergy, 200uM EGCG interventionfor 3h	Model=Positive; RAW_FILE_NAME=E200-3A.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-3B	Treatment:After allergy, 200uM EGCG interventionfor 3h	Model=Positive; RAW_FILE_NAME=E200-3B.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-3C	Treatment:After allergy, 200uM EGCG interventionfor 3h	Model=Positive; RAW_FILE_NAME=E200-3C.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-3D	Treatment:After allergy, 200uM EGCG interventionfor 3h	Model=Positive; RAW_FILE_NAME=E200-3D.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-3A	Treatment:After allergy, 500uM EGCG interventionfor 3h	Model=Positive; RAW_FILE_NAME=E500-3A.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-3B	Treatment:After allergy, 500uM EGCG interventionfor 3h	Model=Positive; RAW_FILE_NAME=E500-3B.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-3C	Treatment:After allergy, 500uM EGCG interventionfor 3h	Model=Positive; RAW_FILE_NAME=E500-3C.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-3D	Treatment:After allergy, 500uM EGCG interventionfor 3h	Model=Positive; RAW_FILE_NAME=E500-3D.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-1A-Negatve	Treatment:Control	Model=Negative; RAW_FILE_NAME=PBS-1A-Negatve.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-1B-N	Treatment:Control	Model=Negative; RAW_FILE_NAME=PBS-1B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-1C-N	Treatment:Control	Model=Negative; RAW_FILE_NAME=PBS-1C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-1D-N	Treatment:Control	Model=Negative; RAW_FILE_NAME=PBS-1D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-1A-N	Treatment:Allergy group	Model=Negative; RAW_FILE_NAME=0-1A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-1B-N	Treatment:Allergy group	Model=Negative; RAW_FILE_NAME=0-1B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-1C-N	Treatment:Allergy group	Model=Negative; RAW_FILE_NAME=0-1C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-1D-N	Treatment:Allergy group	Model=Negative; RAW_FILE_NAME=0-1D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-1A-N	Treatment:After allergy, 10uM curcumin interventionfor 1h	Model=Negative; RAW_FILE_NAME=C10-1A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-1B-N	Treatment:After allergy, 10uM curcumin interventionfor 1h	Model=Negative; RAW_FILE_NAME=C10-1B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-1C-N	Treatment:After allergy, 10uM curcumin interventionfor 1h	Model=Negative; RAW_FILE_NAME=C10-1C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-1D-N	Treatment:After allergy, 10uM curcumin interventionfor 1h	Model=Negative; RAW_FILE_NAME=C10-1D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-1A-N	Treatment:After allergy, 30uM curcumin interventionfor 1h	Model=Negative; RAW_FILE_NAME=C30-1A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-1B-N	Treatment:After allergy, 30uM curcumin interventionfor 1h	Model=Negative; RAW_FILE_NAME=C30-1B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-1C-N	Treatment:After allergy, 30uM curcumin interventionfor 1h	Model=Negative; RAW_FILE_NAME=C30-1C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-1D-N	Treatment:After allergy, 30uM curcumin interventionfor 1h	Model=Negative; RAW_FILE_NAME=C30-1D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-1A-N	Treatment:After allergy, 200uM EGCG interventionfor 1h	Model=Negative; RAW_FILE_NAME=E200-1A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-1B-N	Treatment:After allergy, 200uM EGCG interventionfor 1h	Model=Negative; RAW_FILE_NAME=E200-1B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-1C-N	Treatment:After allergy, 200uM EGCG interventionfor 1h	Model=Negative; RAW_FILE_NAME=E200-1C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-1D-N	Treatment:After allergy, 200uM EGCG interventionfor 1h	Model=Negative; RAW_FILE_NAME=E200-1D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-1A-N	Treatment:After allergy, 500uM EGCG interventionfor 1h	Model=Negative; RAW_FILE_NAME=E500-1A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-1B-N	Treatment:After allergy, 500uM EGCG interventionfor 1h	Model=Negative; RAW_FILE_NAME=E500-1B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-1C-N	Treatment:After allergy, 500uM EGCG interventionfor 1h	Model=Negative; RAW_FILE_NAME=E500-1C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-1D-N	Treatment:After allergy, 500uM EGCG interventionfor 1h	Model=Negative; RAW_FILE_NAME=E500-1D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-3A-N	Treatment:Control	Model=Negative; RAW_FILE_NAME=PBS-3A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-3B-N	Treatment:Control	Model=Negative; RAW_FILE_NAME=PBS-3B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-3C-N	Treatment:Control	Model=Negative; RAW_FILE_NAME=PBS-3C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	PBS-3D-N	Treatment:Control	Model=Negative; RAW_FILE_NAME=PBS-3D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-3A-N	Treatment:Allergy group	Model=Negative; RAW_FILE_NAME=0-3A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-3B-N	Treatment:Allergy group	Model=Negative; RAW_FILE_NAME=0-3B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-3C-N	Treatment:Allergy group	Model=Negative; RAW_FILE_NAME=0-3C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	0-3D-N	Treatment:Allergy group	Model=Negative; RAW_FILE_NAME=0-3D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-3A-N	Treatment:After allergy, 10uM curcumin interventionfor 3h	Model=Negative; RAW_FILE_NAME=C10-3A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-3B-N	Treatment:After allergy, 10uM curcumin interventionfor 3h	Model=Negative; RAW_FILE_NAME=C10-3B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-3C-N	Treatment:After allergy, 10uM curcumin interventionfor 3h	Model=Negative; RAW_FILE_NAME=C10-3C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C10-3D-N	Treatment:After allergy, 10uM curcumin interventionfor 3h	Model=Negative; RAW_FILE_NAME=C10-3D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-3A-N	Treatment:After allergy, 30uM curcumin interventionfor 3h	Model=Negative; RAW_FILE_NAME=C30-3A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-3B-N	Treatment:After allergy, 30uM curcumin interventionfor 3h	Model=Negative; RAW_FILE_NAME=C30-3B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-3C-N	Treatment:After allergy, 30uM curcumin interventionfor 3h	Model=Negative; RAW_FILE_NAME=C30-3C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	C30-3D-N	Treatment:After allergy, 30uM curcumin interventionfor 3h	Model=Negative; RAW_FILE_NAME=C30-3D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-3A-N	Treatment:After allergy, 200uM EGCG interventionfor 3h	Model=Negative; RAW_FILE_NAME=E200-3A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-3B-N	Treatment:After allergy, 200uM EGCG interventionfor 3h	Model=Negative; RAW_FILE_NAME=E200-3B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-3C-N	Treatment:After allergy, 200uM EGCG interventionfor 3h	Model=Negative; RAW_FILE_NAME=E200-3C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E200-3D-N	Treatment:After allergy, 200uM EGCG interventionfor 3h	Model=Negative; RAW_FILE_NAME=E200-3D-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-3A-N	Treatment:After allergy, 500uM EGCG interventionfor 3h	Model=Negative; RAW_FILE_NAME=E500-3A-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-3B-N	Treatment:After allergy, 500uM EGCG interventionfor 3h	Model=Negative; RAW_FILE_NAME=E500-3B-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-3C-N	Treatment:After allergy, 500uM EGCG interventionfor 3h	Model=Negative; RAW_FILE_NAME=E500-3C-N.RAW
SUBJECT_SAMPLE_FACTORS           	-	E500-3D-N	Treatment:After allergy, 500uM EGCG interventionfor 3h	Model=Negative; RAW_FILE_NAME=E500-3D-N.RAW
#COLLECTION
CO:COLLECTION_SUMMARY            	RBL-2H3 cells were incubated with 200 ng/mL of IgE for 18 h, followed by
CO:COLLECTION_SUMMARY            	co-stimulation with 500 ng/mL DNP-BSA for the Alg group, polyphenolic substances
CO:COLLECTION_SUMMARY            	(curcumin or EGCG) and 500 ng/mL DNP-BSA for the intervention group, and the
CO:COLLECTION_SUMMARY            	same volume of PBS solution for the PBS group. The cell samples were collected
CO:COLLECTION_SUMMARY            	at two different time points, 1 h and 3 h after the effect, respectively.
CO:SAMPLE_TYPE                   	Cultured cells
#TREATMENT
TR:TREATMENT_SUMMARY             	RBL-2H3 cells were incubated with 200 ng/mL of IgE for 18 h, followed by
TR:TREATMENT_SUMMARY             	co-stimulation with 500 ng/mL DNP-BSA for the Alg group, polyphenolic substances
TR:TREATMENT_SUMMARY             	(curcumin or EGCG) and 500 ng/mL DNP-BSA for the intervention group, and the
TR:TREATMENT_SUMMARY             	same volume of PBS solution for the PBS group.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	The MeOH/MTBE/H2O system was used for the extraction of lipid metabolites from
SP:SAMPLEPREP_SUMMARY            	cell samples. Cell culture dishes stored at -80 °C were first removed on ice
SP:SAMPLEPREP_SUMMARY            	and 1 mL of methanolic solution containing internal standards was added,
SP:SAMPLEPREP_SUMMARY            	consisting of 1 μg/mL FFA (C16:0)-d3 and FFA (C18:0)-d3, 0.87 μg/mL LPC (19:0)
SP:SAMPLEPREP_SUMMARY            	and SM (d18:1/12:0), 1.12 μg/mL PC (38: 0), 0.92 μg/mL PE (30:0), 0.67 μg/mL
SP:SAMPLEPREP_SUMMARY            	TG (45:0), and 0.47 μg/mL Cer (d18:1/17:0). The cells were transferred to 5 mL
SP:SAMPLEPREP_SUMMARY            	Eppendorf centrifuge tubes by scraping with a cell scraper, adding 2.5 mL of
SP:SAMPLEPREP_SUMMARY            	MTBE and vortexing for 30 s. The cells were further shaken for 30 min at 10 °C
SP:SAMPLEPREP_SUMMARY            	and 1000 rpm using a thermostatic mixer. 750 μL of ultrapure water was added,
SP:SAMPLEPREP_SUMMARY            	vortexed for 60 s and allowed to stand for 5 min, and then centrifuged at 12,000
SP:SAMPLEPREP_SUMMARY            	g for 10 min at 6 °C. After separation of the two phases, 400 μL of the
SP:SAMPLEPREP_SUMMARY            	hydrophobic phase was collected and dried in a cryogenic vacuum centrifuge
SP:SAMPLEPREP_SUMMARY            	concentrator, and the resulting lyophilized sample was stored at -80 °C.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Thermo Dionex Ultimate 3000
CH:COLUMN_NAME                   	Waters Acquity BEH C8 (100 x 2.1mm, 1.7um)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive HF-X Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	Xcalibular
MS:MS_RESULTS_FILE               	ST002384_AN003884_Results.txt	UNITS:Peak area	Has m/z:Yes	Has RT:Yes	RT units:Minutes
#END